RE: Up again17 Mar 2025 12:17
Tiziana Life Sciences Ltd.
NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the CEO of Tiziana Life Sciences, Ivor Elrifi, will be presenting during a fireside chat at the 37th Annual ROTH Conference and host 1x1 investor meetings. The Conference is being held March 16-18, 2025, in Dana Point, California. This year’s event will consist of 1-on-1 / small group meetings, analyst-selected fireside chats, industry keynotes and panels with executive management attending from approximately 450 private and public companies in a variety of growth sectors.
Presentation Details:
Date: Tuesday, March 18, 2025
Time of Presentation: 12:00 pm PST / 15:00 pm ET / 19:00 pm GMT
Format: Virtual Fireside Chat
1x1 Meetings: Please contact your ROTH representative.
You can register online to view the webcast here: Link https://event.summitcast.com/view/YsA9Ty4sRyad4m3F6KNZ7x/guest_book?session_id=gqgiLZRZ5HCwVprZf85NFv